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ABSTRACT

The present invention provides, inter alia, nucleic acids
Which encode P450s in corn that, When expressed in the
presence of a reductase, metabolize compounds exemplary
of several distinct classes of insecticides and herbicides. The
invention also includes amino acids encoded by the nucleic
acids, as Well as vectors, cells and eukaryotes comprising the
nucleic or amino acid compounds. Also included are meth

ods using the materials provided.
14 Claims, 11 Drawing Sheets
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CYTOCHROME P450 ENZYMES AND
RELATED COMPOUNDS AND METHODS

of information available to the applicant, and does not
constitute any admission as to the accuracy of the dates or
contents of these documents.

This application claims priority to US. Provisional
Patent Application Ser. No. 60/092,596, ?led Jul. 12, 1998.

SUMMARY OF THE INVENTION

It is therefore an object of the present invention to provide

BACKGROUND OF THE INVENTION
Plant cytochrome P450s are noW knoWn to be involved in
the metabolism and detoxi?cation of numerous pesticides.
Much of the evidence has been gathered via traditional

compounds useful to protect plants from the otherWise
detrimental effects of a broad spectrum of pesticides, includ

ing negative effects of herbicides and/or insecticides.
10

chemistry techniques (Shuler, 15 Crit Rev Plant Sci 235
(1996); BolWell et al., 37 Phytochemistry 1491(1994) and
Frear et al., 8 Phytochemistry 2157 (1969)), or through use
of mammalian or bacterial genes in plants (Shiota et al., 106
Plant Physiol 17 (1994) and O’Keefe et al., 105 Plant

cide safeners.
15

It is yet another object to provide tools for pesticide
metabolite analysis, including herbicide and/or insecticide
metabolite analysis.
20

for example, “a protein” or “a nucleic acid molecule” refers

several soybean P450s Were cloned and one Was shoWn to

to one or more of those compounds or at least one com

metaboliZe linuron and chlortoluron (Presentation, Weed Sci

pound. As such, the terms “a” (or “an”), “one or more” and
25

The most up-to-date source of information on plant P450s
is on the internet. As of Jul. 12, 1998, most of the informa
tion related to the CYP72A subfamily of P450s on that Web

site pertained to the Catharanthus (rosens) P450s, although
Nicotiana and Arabidopsis P450s Were also characteriZed.
The site implied the existence of tWo CYP72 P450s from
Zea mays, although the sequence information Was not dis
closed for either. The tWo Were assigned separate identi?ers

30

no accession number (318 amino acids)
Mike Persons and Mary Schuler
PCR 4 formerly CYp95A1 (missnamed due to a frame
shift in the PCR fragment)
CPY72A1 Zea mays (maiZe)

“at least one” can be used interchangeably herein. It is also
to be noted that the terms “comprising”, “including”, and
“having” can be used interchangeably. Furthermore, a com
pound “selected from the group consisting of” refers to one
or more of the compounds in the list that folloWs, including
mixtures (i.e., combinations) of tWo or more of the com
pounds. According to the present invention, an isolated, or
biologically pure, protein or nucleic acid molecule is a

compound that has been removed from its natural milieu. As
such, “isolated” and “biologically pure” do not necessarily

by the Web site developer. Speci?cally, the Web site stated:
CYP72A Zea mays

Moreover, for the purposes of the present invention, the
term “a” or “an” entity refers to one or more of that entity;

ron (Pierrel, 224 Eur J Biochem 835 (1994). Likewise,

Soc ofAmer (February 1997)).

It is yet another object to provide assays for discovery of
neW pesticides, including herbicide and/or insecticide
assays.

Physiol 473 (1994)).
Recently, hoWever, endogenous plant P450s have been
cloned and expressed using molecular biology techniques.
For example, CYP73A1, a cytochrome isolated from J erusa
lem artichoke Was recently shoWn to metaboliZe chlortolu

It is a further object to provide assays for discovery of

neW pesticide safeners, including herbicide and/or insecti

35

re?ect the extent to Which the compound has been puri?ed.
An isolated compound of the present invention can be
obtained from its natural source, can be produced using

molecular biology techniques or can be produced by chemi
cal synthesis. In this application, the term “pesticide” is used
40

as a generic Word for both herbicides and insecticides.

no accession number

Mike Barrett
clone A8 most like PCR fragment PCR4 from Mike
Persans and Mary Schuler. The PCR4 fragment Was

BRIEF DESCRIPTION OF THE DRAWINGS

missnamed as CYP95A1 due to a frame shift error in 45

the sequence in the I helix region, also like Arabi

dopsis GSS BAC end fragment B24203 (67?
identical) submitted to nomenclature committee.

FIG. 1 is the DNA (SEQ ID NO 1) and deduced amino
acid sequence (SEQ ID NO 2) of CY P72A1.
FIG. 2 is the DNA (SEQ ID NO 3) and deduced amino
acid sequence of CYP92A1 (SEQ ID NO 4); and
FIG. 3 is a spectra demonstrating expression of 72A1 in

The above can be found at http://drnelson.utmem.edu/
biblioD.html#72A.

yeast microsomes; and
FIG. 4 shoWs comparisons of nucleotide and protein

The concept of a multiple pesticide metaboliZing P450 in

identity of CYP72A1 and CYP92A1 With knoWn sequences.
It also shoWs protein similarity of CYP72A1 and CYP92A1
With knoWn sequences; and
FIG. 5 is a genomic blot shoWing induction of expression
of CY72A1 and CYP92A1 by NA-treatment; and
FIG. 6 is the hybridiZation pattern of CYP72A1; and
FIG. 7 is the hybridiZation pattern of CYP92A1; and
FIG. 8 shoWs chromatographs of the production of the

corn Was ?rst proposed during the Ph.D. Dissertation of
Laura Boldt on Apr. 15, 1992. FIG. 12 in the present
disclosure is the table from her thesis, Which indicates that
corn line GA209 is not only sensitive to bentaZon, but also

55

to the herbicides imaZethapyr, nicosulfuron and primisulfu
ron. In further research by Roger Baerg, it Was shoWn that
the in-vitro metabolism of the herbicides nicosulfuron,

chlorimuron, bentaZon, imaZethapyr, and the insecticide
malathion are all inhibited by the insecticide terbufos

60

bentaZon metabolites, in comparison to appropriate control

65

treatments; and
FIG. 9 shoWs chromatographs of the production of the
chlortoluron metabolites, in comparison to appropriate con
trol treatments; and
FIG. 10 shoWs chromatographs of the production of the

sulfone (FIG. 13—from Baerg et al., 55 Pesticide Biochem

istry and Physiology 10 (1996), initially disclosed Nov. 4,
1994 in dissertation form).
Citation of the above documents is not intended as an

admission that any of the foregoing is pertinent prior art. All
statements as to the date or representation as to the contents

malathion metabolites, in comparison to appropriate control

of these documents is based on subjective characteriZation

treatments; and

US 6,380,465 B1
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FIG. 11 shows chromatographs of the production of the
chlorimuron metabolites, in comparison to appropriate con

various commercial sources, including Clontech

Laboratories, Inc. (Palo Alto, Calif.), Stratagene (La Jolla,
Calif.), Invitrogen (Carlsbad, Cailf.), NeW England Biolabs
(Beverly, Mass.) and Promega (Madison, Wis.). Preferred

trol treatments.

DETAILED DESCRIPTION OF THE
INVENTION

vectors are those Which are capable of transferring the

sequences disclosed herein into plant cells or plant parts.
Also provided are cells comprising the nucleic acids, in
particular, SEQ ID NO 1. Preferred cells are eukaryotic

The present invention provides, inter alia, nucleic acids
Which encode P450s in corn that, When expressed in the
presence of a reductase, metabolize compounds exemplary
of several distinct classes of insecticides and herbicides. The
CYP72A1 P450 has been shoWn to metaboliZe the herbi

10

ferred. The most preferred strains are WAT 11 and WAT 21,
With WAT 11 preferred as betWeen the tWo.

cides bentaZon (tradename Basagran), chlorimuron
(tradename Classic and others), and chlortoluron (used in
Europe), and the insecticide malathion (marketed under

many tradenames). Representative chromatographs shoWing

15

invention also includes variants due to laboratory
manipulation, such as, but not limited to, variants produced

priate control treatments, are shoWn in FIGS. 8—11.
The above pesticides are representative of unclassi?ed

during polymerase chain reaction ampli?cation or site

heterocyclic herbicides (bentaZon), sulfonylurea herbicides

directed mutagenesis. It is also Well knoWn that there is a
substantial amount of redundancy in the various codons

(chlorimuron), substituted urea herbicides (chlortoluron),
and organophosphate insecticides (malathion). The

Which code for speci?c amino acids. Therefore, this inven

CYP72A1 P450 thus displays a broad substrate range. Based

tion is also directed to those nucleic acid sequences Which
contain alternative codons Which code for the eventual
translation of the identical amino acid. Also included Within
the scope of this invention are mutations either in the nucleic
acid sequence or the translated protein Which do not sub

on genetic and biochemical data gathered prior to the

cloning and expression of the CYP72A1 P450, additional
substrates in the sulfonylurea family of herbicides

(particularly nicosulfuron, primisulfuron, prosulfuron, and
rimsulfuron), the herbicide imaZethapyr (tradename Pursuit

stantially alter the ultimate physical properties of the
expressed protein. For example, substitution of valine for
leucine, arginine for lysine, or asparagine for glutamine may

and others, from the imidaZolinone family of herbicides), the
herbicide fumetsulam (tradename Broadstrike and others,

from the triaZolopyrimidine family of herbicides), experi

not cause a change in functionality of the polypeptide.
Lastly, a nucleic acid sequence homologous to the exempli
?ed nucleic acid molecules (or allelic variants or degener

mental herbicides under development related to

sulcantrione, and other organophosphate insecticides Would
be metaboliZed by the CYP72A1 P450. HoWever, the

ates thereof) may have at least 85%, preferably 90%, and
35

herbicides alachlor, 2,4-D, linuron, dicamba and chlorsul
furon.
The present invention can be used in the development of
herbicide resistant crops. For instance, crops transformed
With SEQ ID NO 1 Would be resistant to herbicides from
several herbicide chemical families having different sites of
action. Historically, herbicide resistant crops that have been
developed are resistant to only one chemical family or
inhibitors of one site of action. The present invention
overcomes many of the limitations of previously developed
herbicide resistant crops. In addition, the invention can be
used in the discovery and development of neW herbicides

40

45

nucleic acid or amino acid sequences. These computer
programs include, but are not limited to, GCGTM (available

from Genetics Computer Group, Madison, Wis.), DNAsisTM
(available from Hitachi SoftWare, San Bruno, Calif.) and
MacVectorTM (available from the Eastman Kodak Company,
NeW Haven, Conn.). A preferred method to determine per
cent identity among amino acid sequences and also among

present invention can also be used to generate P450
55

tration studies. Moreover, the present invention includes the
use of the nucleic acid compounds to generate nucleic acid
probes to test for the induction activity of neW candidate
60

Therefore, the present invention includes nucleic acid
compounds comprising SEQ ID NO 1. The nucleic acid
Which is SEQ ID NO 1 is preferred. HoWever, portions of
SEQ ID NO 1 are also provided for the use as primers and

ID NO 1 are also provided. Vectors may be obtained from

nucleic acid sequences includes using the Compare function
by maximum matching Within the program DNAsis Version
2.1 using default parameters.
In another embodiment of the present invention, a pre
ferred nucleic acid molecule includes an isolated nucleic
acid molecule Which is at least about 50 nucleotides, or at

safeners. It can also provide probes and primers for identi

Vectors comprising the nucleic acids, in particular, SEQ

sequences and also among nucleic acid sequences include
analysis using one or more of the commercially available

computer programs designed to compare and analyZe

yeast cells, to demonstrate and study the metabolism of
candidate pesticide molecules by the CYP72A1 P450. The

probes for molecular biology research or chemical assays.

betWeen tWo nucleic acid sequences. These computer pro
grams include various knoWn methods to determine the

percentage identity and the number and length of gaps
betWeen hybrid nucleic acid molecules. Preferred methods
to determine the percent identity among amino acid

The gene can also be expressed in other plants, such as
Arabidopsis thaliana, or in a heterologous system, such as

?cation of additional P450s.

most preferably 95% sequence identity With a nucleic acid
molecule in the sequence listing.
It is knoWn in the art that there are commercially available

computer programs for determining the degree of similarity

and other pesticides.

produced pesticide metabolites needed for pesticide regis

Included Within the scope of the present invention, With
particular regard to the nucleic acids above, are allelic

variants, degenerate sequences and homologues. The present

the production of the metabolites, in comparison to appro

CYP72A1 P450 does not metaboliZe all substrates Which
have been tested. UnmetaboliZed substrates include the

cells. Most preferred are yeast (the Saccharomycetes) and
plants. Any species of yeast are consider Within the scope of
the present invention; hoWever, S. cerevisiae cells are pre

65

least about 150 nucleotides, and Which hybridiZes under
conditions Which preferably alloW about 50% base pair
mismatch, more preferably under conditions Which alloW
about 45% base pair mismatch, more preferably under
conditions Which alloW about 40% base pair mismatch,
more preferably under conditions Which alloW about 35%
base pair mismatch, more preferably under conditions Which
alloW about 30% base pair mismatch, more preferably under

US 6,380,465 B1
5

6

conditions Which allow about 25% base pair mismatch,

invention: soybean, beet, tobacco, Wheat, barley, poppy,
rape, sun?ower, alfalfa, sorghum, rose, carnation, gerbera,

more preferably under conditions Which allow about 20%

base pair mismatch, more preferably under conditions Which
alloW about 15% base pair mismatch, more preferably under
conditions Which alloW about 10% base pair mismatch and
even more preferably under conditions Which alloW about
5% base pair mismatch With a nucleic acid molecule
selected from the group consisting of SEQ ID NO 1 and
SEQ ID NO 3.
Also Well knoWn to those skilled in the art is hoW

carrot, tomato, lettuce, chicory, pepper, melon and cabbage.
In another aspect of the present invention, there are
included nucleic acid compounds comprising SEQ ID NO 3.
Eukaryotes comprising a nucleic acid compound of SEQ ID
NO 3 is speci?cally provided. MaiZe is the preferred eukary
ote.
10

base-pair mismatch, i.e. differences betWeen tWo nucleic
acid molecules being compared, including non
complementarity of bases at a given location, and gaps due
to insertion or deletion of one or more bases at a given

location on either of the nucleic acid molecules being
compared, Will affect Tm or Td for nucleic acid molecules of
different siZes. For example, Tm decreases about 1° C. for
each 1% of mismatched base-pairs for hybrids greater than
about 150 bp, and Td decreases about 5° C. for each

mismatched base-pair for hybrids beloW about 50 bp. Con

15

contacting the test compound With a eukaryote of the present
invention, and a second step of determining if the eukaryote
is induced to produce a nucleic acid of the present invention,
in particular, SEQ ID NO 1, RNA transcribed therefrom, or
SEQ ID NO 2. Those in the art realiZe that the second step
can be accomplished by routine means, such as, but not

limited to, PCR analysis, genomic southern blot analysis, or
Western blot analysis.
20

ditions for hybrids betWeen about 50 and about 150 base
pairs can be determined empirically and Without undue

experimentation using standard laboratory procedures Well
knoWn to those skilled in the art. These simple procedures
alloW one skilled in the art to set the hybridiZation conditions 25

(by altering, for example, the salt concentration, the forma

mide concentration or the temperature) so that only nucleic

acid hybrids With less than a speci?ed % base-pair mismatch
Will hybridiZe. Stringent hybridiZation conditions are com
monly understood by those skilled in the art to be those

The present invention also provides methods to determine
the ability of a test compound to protect a plant from the
deleterious effects of a pesticide, comprising a ?rst step of

Other methods herein provided are those useful for deter

mining the ability of a test compound to be metaboliZed by
a eukaryote of the present invention, comprising a ?rst step
of contacting the eukaryote With the test compound and a
second step of determining the existence of metabolites. As
above, detection of metabolites is routine in the art. For
example, the test compound can carry a physical label,
usually a radioactive or ?uorescent label. Typical radioactive

labels are 3H, 14C and 23P.
30

Also provided are methods to express an amino acid

experimental conditions that Will alloW hybridiZation

compound of the present invention, comprising transform

betWeen molecules having about 30% or less base-pair
mismatch (i.e., about 70% or greater identity). Because one

ing a eukaryote With a SEQ ID NO 1, and inducing SEQ ID
NO 1 With napthalic acid.
In another embodiment, there are provided methods to
cause pesticide resistance in a plant, comprising causing the
plant to express an amino acid compound of claim 14,
provided that the pesticide to Which the plant is resistant is
selected from the group consisting of: heterocyclic
herbicides, sulfonylurea herbicides, substituted urea herbi
cides and organophosphate insecticides.
Lastly, the present invention includes methods to alter the

skilled in the art can easily determine Whether a given
nucleic acid molecule to be tested is less than or greater than
about 50 nucleotides, and can therefore choose the appro

35

priate formula for determining hybridiZation conditions, he
or she can determine Whether the nucleic acid molecule Will

hybridiZe With a given gene under stringent hybridiZation
conditions and similarly Whether the nucleic acid molecule
Will hybridiZed under conditions designed to alloW a desired
amount of base pair mismatch.
Transformation of cells With the compounds of the present
invention can be accomplished according to knoWn proce

dures. For example, infective, vector-containing bacterial
strains (such as Agrobacterium rhizogenes and Agrobacte

40

naturally-occurring expression pattern of the nucleic acids
provided so as to either delay or speed expression. In

particular, in order to practice the altered expression pattern
45

aspect of the present invention, one Would construct a vector

Which provided for either an early or late promoter in

rium tumefaciens) may be used for transformation.
Zambryski, 43 Ann. Rev. Pl. Physiol. Pl. Mol. Biol. 465
(1992). The folloWing procedures are also Well-knoWn:
Pollen-tube transformation [Zhon-xun et al., 6 Plant Molec.
Bio. 165 (1988)]; direct transformation of germinating seeds

conjunction With the present sequences. For instance, the
folloWing promoters Would be useful in early expression of
the present sequences:
Ogs4B (Tsuchiya et al., 36 Plant Cell Physiology 487

[Toepfer et al., 1 Plant Cell 133 (1989)]; polyethylene glycol

TA29 (KoltunoW et al., 2 Plant Cell 1201 (1990)
A3 & A9 (Paul et al., 19 Plant Molecular Biology 611

or electroporation transformation [Christou et al., 84 Proc.
Nat. Acad. Sci. 3662 (1987)]; and biolistic processes [Yang
& Cristou, Particle Bombardment Technology for Gene
Transfer (1994)]. The transformed cells are also Within the
scope of the present invention.

(1994)
(1992)
55

described above, the construct optionally contains, for
example, a 35S promoter. Transformation of plants With

The transformed cells may be induced to form trans

formed plants via organogenesis or embryogenesis, accord
ing to the procedures of Dixon Plant Cell Culture: A

these sequences Would be according to knoWn procedures as
described above. Plants can be groWn according to knoWn
60

PracticalApproach (IRL Press, Oxford 1987).

procedures.
Proteins Which Would result from expression of the
nucleic acid molecules herein disclosed are preferred, With

Moreover, any plants or plant cells or parts are Within the

scope of the present invention. For instance, Whole plants,
embryos and seeds are considered part of the present
invention, as Well as shoots, ?oWers, leaves, leaf tips and the
like. The most preferred plant is maiZe, although any of the
folloWing plants are also Within the scope of the present

In order to then constitutively express the sequences

the proteins Which Would result from expression of the

exempli?ed compounds being most preferred. It is under
65

stood that proteins Which Would result from expression of
allelic variants of the exempli?ed sequences, as Well as

proteins Which Would result from the expression of nucleic

US 6,380,465 B1
7

8

acid molecules Which hybridize under stringent hybridiZa

hybridiZed under high stringency conditions. To estimate the
copy number, Southern blot analysis Was performed using

tion conditions to the nucleic acid molecules exempli?ed are
Within the scope of the present invention as Well. Lastly, an
amino acid sequence substantially homologous to a referent

genomic DNA from 3343IR maiZe Which Was digested With
SacI EcoRV, EcoRI, HindIII, and BamHI. The analysis Was

protein Will have at least 85% sequence identity, preferably
90%, and most preferably 95% sequence homology With the

carried out under high stringency (65 degrees Celsius in
0.1><SSC and 0.1% SDS).

amino acid sequence of a referent protein or a peptide
thereof. For example, an amino acid sequence is substan

tially homologous to a referent P450 protein if, When aligned

Example 2

With a referent P450 protein, at least 85% of its amino acid
residues are the same. Speci?cally provided are amino acid

Expression and Sequence Con?rmation of MaiZe P450s in

10

Yeast

compounds comprising SEQ ID NO 2 and/or SEQ ID NO 3.
The minimal siZe of a protein homolog of the present

Both genes (CYP72A1 and CYP92A1), obtained as
described in Example 1, Were introduced into pYeDP60

invention is a siZe sufficient to be encoded by a nucleic acid

molecule capable of forming a stable hybrid (i.e., hybridiZe
under stringent hybridiZation conditions) With the comple

vector for yeast expression. CYP72A1 Was introduced as a
15

mentary sequence of a nucleic acid molecule encoding the

corresponding natural protein. As such, the siZe of the
nucleic acid molecule encoding such a protein homolog is
dependent on nucleic acid composition and percent homol
ogy betWeen the nucleic acid molecule and complementary

20

sequence. It should also be noted that the extent of homol
ogy required to form a stable hybrid can vary depending on

Whether the homologous sequences are interspersed
throughout the nucleic acid molecules or are clustered (i.e.,
localiZed) in distinct regions on the nucleic acid molecules,
The minimal siZe of such nucleic acid molecules is typically
at least 12 to about 15 nucleotides in length if the nucleic

25
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Example 3

nucleotides and may be 25 nucleotides in length. Thus, the
minimal siZe of a cytochrome P450 protein homolog of the

Induction of CYP72A1 and CYP92A1 by Napthalic Acid
and Con?rmation of Copy Number
35

induced signi?cantly less (FIG. 5). Based on the results of

the genomic Southern blot analysis, the hybridiZation pat
40

45

EXAMPLES

tion patterns of the corresponding cDNAs. Distinct patterns
indicated that individual probes did not cross-hybridiZe to
other P450 genes ad shoWed that CYP72A1 is likely to be
present as tWo copies in the genome of 3343IR maiZe, and
CYP92A1 as a single copy (FIGS. 6 & 7). Certain physico
chemical characteristics for the deduced proteins, antigenic
ity and secondary structure Were calculated using NetWork

Example 4
Optional Strategies for Cloning and Expressing CYP72A1

MaiZe P450s
A maiZe cDNA library Was constructed from napthalic

anhydride (NA)-treated Pioneer 3343IR 3.5-day-old seed
lings using lambda-ZAPII vector kit (Stratagene).
55

and CYP92A1
Prepare RNA from NA-induced maiZe shoots. One or
more of the folloWing techniques can then be used: primers

can be designed from the ?anking heme region according to

Ohbayashi et al, 1993. Alternatively, degenerate 5‘ primers

Clones Were separated into tWo subsets based on the simi

larity of the sequencing information. The longest clones

terns Were consistent With those predicted from the restric

Protein Sequence Analysis at IBCP, France.

Example 1
Cloning, Sequencing and Estimating Copy Number of

The library Was screened under high stringency condi
tions by tWo P450 clones generated by PCR to heme-binding
region and inducible by naptalic acid. Both PCR products
Were labeled With [32P]-dCTP by random priming method.

The expression of both genes (CYP72A1 and CYP92A1)
Was induced by NA-treatment, but to different extents:
CYP72A1 Was highly induced, Whereas CYP92A1 Was

Preferably, the preferred siZe of a protein encoded by a
nucleic acid molecule of the present invention is a portion of
the protein that Which is at least 30 amino acids, more
preferably at least 35 amino acids and even more preferably
at least 45 amino acids in length.

additional 56 clones Which Were sequenced at the ends. All
the sequences represented one of the tWo genes. CYP 72A1
Was isolated presumably as a full-length gene, hoWever,
CYP92A1 Was still missing 30—50 bases at the amino

P450s. See FIG. 4.

bases in length if they are AT-rich. As such, the minimal siZe

present invention is from about 4 to about 6 amino acids in
length. There is no limit, other than a practical limit, on the
maximal siZe of such a nucleic acid molecule in that the
nucleic acid molecule can include gene, and entire gene,
multiple genes, or portions thereof. The preferred siZe of a
protein encoded by a nucleic acid molecule of the present
invention depends on Whether a full-length, fusion, multi
valent or functional portion of such a protein is desired.

Approximately 8><106 plaque-forming units Were
screened by tWo P450 fragments. 73 positive clones Were
isolated and sequenced. Sequence homology Was used to
separate these clones into tWo groups. Secondary screening
using the cDNA inserts from the longest clones identi?ed an

terminus after rescreening. These genes and their deduced
amino acid sequences shoWed homology to several plant

acid molecules are GC-rich and at least about 15 to about 17

of a nucleic acid molecule used to encode a protein homolog
of the present invention is from about 12 to about 18

full length gene With in-frame Met 1 and 8 as the start
codons, While CYP92A1 Was modi?ed for the expression.

60

to heme region may be uses, With 3‘ primer to the poly Atail,
according to Meij er et al., 1993). Another acceptable method
is to use nested PCR, With the ?rst round using 5‘ primer to

from each subset Were completely sequenced. Both clones

region upstream from heme region, according to Frey et al.,

Were truncated at the 5‘-end. The library Was rescreened
using the longer clones. One of the genes Was recovered as

1995.
Clone selection criteria can include identi?cation of
induction of message With NA, identi?cation of RFLP

a full length (CYP72A1), Whereas the second gene
(CYP92A1) Was still truncated.
Northern blot analysis Was performed With total RNA

isolated from control and agarose gel electrophoresis and

65

co-segregation With phenotypes in repulsion phase homoZy
gotes and/or differential expression betWeen GA209 and ie.

B73 (Wild type).

US 6,380,465 B1
9

10

Expression strategies include using both full length or
truncated (Met 8 start site) CYP72A1 cDNA in yeast strains
WATll, WAT21 W (R) from Philippe Urban and Denis

incubated With [14C]-labeled substrates and products ana

lyZed by HPLC.

Pornpon, With, optionally, yeast vector pYeDP60. Expres
sion is ideall

achieved With full len th cDNA and WATll.

5

.

.

.

Expression nliay also require 36 hougs rather than 24 hours

Althollgh the present menu?“ has been fully descllbed

of galactose induction prior to rnicrosorne preparation. Glu-

hereln’ It IS to be noted that V_anOu_S Changes and modl?ca'

C056 ($61) or galactose (SL1) media prior to induction Win
tions are apparent to those skilled in the art. Such changes
give expression
and rnodi?cations are to be understood as included Within
Metabolisrn experiments can be accomplished using 10 the 560116 0f the present invention as de?ned by the
rnicrosornes prepared from yeast cells. The substrates can be
appended claims.

SEQUENCE LISTING

<l60> NUMBER OF SEQ ID NOS: 4

<2 10>
<211>
<2 12>
<213>

SEQ ID NO 1
LENGTH: 1584
TYPE: DNA
ORGANISM: Zea mays

<400> SEQUENCE: l

atggcgacct gcgatctgct gatgctgcgg gaagcatctc cgtgggcgct ggccggcgcg

60

gtggcgtccg tgtcgctgtt gtggctggtg gcctggacgc tggagtgggc ctggtggaca

120

ccttggcggc tcgatcgggc cctgcgggcc cagggcctca atggcaccag gtaccgcctc

180

ttcaccggcg acctgaggga aaccgcccgg gttaaccggg aggctcgcaa gaagccgctg

240

ccgctcggct gccacgacat caccccacgc gtgcagccca tgcatcacag caccatcaag

300

gaatacggga aactatcgtt cacctggttc ggcccaacac caagggtgat gattcctgac

360

ccagagttag tcaaagaggt gctgtctaat aagtttggcc actttggcaa accaaggagt

420

agccgcattg ggaggttgct agccaacggg cttgtaaatc atgatggtga aaaatgggca

480

aagcacagga gaattcttaa tcctgcattt caccatgaaa aaataaaggg gatgatgcca

540

gtattttcta cctgctgtat tgaaatgatt actagatggg ataattcaat gtcttccgag

600

ggatcttctg agatagatgt ctggcctgag ttccagaatc ttactggaga tgttatctca

660

agaactgcgt ttgggagcaa ctatcaagaa gggaggagaa tttttgagct acaaggagaa

720

ctagctgaac gcctcatcca atctgttcag acaatattta tcccaggcta ttggttcttg

780

cccaccaaaa acaacagaag gatgagagca atcgatgtag agatccgcaa aattctccgt

840

gaaataattg ggaagagaga gaaggatact aaaaacagag aaacaaataa agatgacttg

900

ctgggcttat tactggagtc aaacacaagg caatcaaatg gaaatgcaag cctgggattg

960

acaacagaag atgtgattga ggaatgcaag ttattttact ttgcaggtat ggagacaaca

1020

tcagtcctgc ttacttggac acttattgtg ctaagcatgc acccagaatg gcaagagaga

1080

gcaagagaag aggttttgag ccactttgga agaaccacac cagattatga tagcttgagc

1140

cgcctcaaga ctgtaaccat gattctacat gaggtcctta ggttgtaccc accggcaacc

1200

tttctaacca gaagaactta taaggaaatg gagctcggtg gaatcaaata tcctgcagga

1260

gtggagctcc ttctgcccgt catcttcatt caccatgatc ccgacatttg gggaaaagac

1320

gcaagcgagt tcaacccaga aaggtttgcc aacggcatct ccagcgcaac caggcatcag

1380

gctgctttct ttccgttcgg agggggcccc aggatctgca tcggccagag ctttgcgttg

1440

ctggaagcca agatgacgct atgcaccatc ctccagcgct tctcgttcga gctctcacca

1500

tcctacaccc acgcgccgta caccgtgata acactgcacc ctcagcacgg tgctcagata

1560

US 6,380,465 B1
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16
-oontinued

165

Ile Ser

Arg Ile Val

170
Leu

Gly Lys Lys Tyr

180

200

Glu Met Val

Asp Glu Phe Phe Ala

210

205
Leu His

Pro

Trp

225

Leu

Lys Arg

Met

Asp Trp

Leu

Asp

Arg Arg

Leu

Met Leu

Asp

Arg

290

Arg Asp

Gly

305

Thr

Asp

Lys

Asn Val

Asp

Lys Ala Ile Thr Gln Asp

Ser Asn Ala Asn Thr Leu Glu

Asn Pro

Arg

Pro

340

Lys Ile

320

Leu Ala

Lys Ala

Asp Arg

Leu Val Thr Glu Ser Asp

350

Tyr Ile Glu Ala Val

355

Leu

Lys Glu Thr Met Arg

360

365

Val His Pro Ala Ala Pro Met Leu Ala Pro His Val Ala
375
Leu Ala

390

Asn Val

Trp Ala Ile Gly Arg Asp

Pro

405

Glu Phe

Arg

Pro Glu

Arg Phe Val Glu

420

His Asp Phe Gln Leu Leu Pro Phe

Gly

Ile Asn Leu Ala Leu

Lys Val
455

Gly

Phe Glu

465

400

Trp Asp Ala

410

Pro Glu
415

Ser

Lys Ile Asp Val Arg Gly

Leu

Gly

430
Ser

Gly Arg Arg

Trp Arg

Met Ala Leu Ser Leu Ala Asn Leu

460
Leu Pro

Asp Gly Val Thr Ala Glu Glu
475

Asp Glu Ala Phe Lys

500

480

Leu Ala Val Pro

485
Leu Met Val Val Ala Glu Pro

Met Cys Pro

445

470

Leu Ser Met

Thr Val Leu Phe Ile

395

440

450
Leu His

Gly

Gly

425

435

Arg Glu Asp

380

Asp Gly Tyr Asp Val

385

Met Glu

335

345

370

Trp Ala

315

330

Glu Leu Asn His Val Ile

Thr Ser Val

Thr Ser

300

325

Leu Pro

Asn Phe

285

310

Val Ser Glu Leu Leu

Arg Val

270

Val Leu Leu Gln Leu Ala

295

Arg

Gly Gly

280

Leu Glu Val Gln Leu Ser

Val Ala

255

Glu

265

275

Leu Pro

Leu Glu

250

260

Leu Ile Ile Ala

Gly Tyr

240

Lys Ala Arg Phe Gly Arg Phe

Val His Asn Glu

Lys Asp

Leu Gln

235

245

Ala

Ala Phe Asn Ile Gly
220

230

Asp

Gly

215

Asp Tyr Ile

Leu

190

Ser Ala Pro Ala Ile Thr Pro Ala Glu Phe

195

Met

Val Met Glu Glu Ala Ala

185

Asp Gly Glu Gly Asp

Arg

175

Arg Lys Phe

490

Arg

Leu Pro Ala

Pro

495

Arg

Leu

505

Tyr Thr Gly
510

Ala

What is claimed is:
1. An isolated nucleic acid molecule, Wherein said nucleic
acid molecule comprises a nucleic acid sequence selected

(b) a nucleic acid sequence Which has at least 95%

identity to SEQ ID NO:3, Wherein said identity can be
determined using the DNAsis computer program and
default parameters; Wherein the nucleic acid sequences
of (a) and (b) each encodes an amino acid having

60

from the group consisting of:
(a) a nucleic acid sequence Which has at least 95% identity
to SEQ ID NO: 1, Wherein said identity can be deter
mined using the DNAsis computer program and default

parameters; and

cytochrome P450 activity.
2. A vector comprising a nucleic acid molecule of claim
65

1.
3. A cell transformed With a nucleic acid molecule of
claim 1.

